![Jens Knobe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jens Knobe
Director/Board Member at SOLIDX AB
Jens Knobe active positions
Companies | Position | Start | End |
---|---|---|---|
SOLIDX AB | Director/Board Member | 2021-06-30 | - |
Independent Dir/Board Member | 2021-06-30 | - | |
Radiometer A/S
![]() Radiometer A/S Medical SpecialtiesHealth Technology Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark. | Sales & Marketing | 2004-12-31 | - |
SARomics Biostructures AB
![]() SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Director/Board Member | - | - |
Knobe Strat&Med AB | Director/Board Member | - | - |
Fastighets AB Swenson & Co. | Director/Board Member | - | - |
Career history of Jens Knobe
Training of Jens Knobe
University of Lund | Graduate Degree |
Statistics
International
Sweden | 6 |
Denmark | 2 |
Operational
Director/Board Member | 4 |
Graduate Degree | 2 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SOLIDX AB | Commercial Services |
Private companies | 4 |
---|---|
Radiometer A/S
![]() Radiometer A/S Medical SpecialtiesHealth Technology Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark. | Health Technology |
SARomics Biostructures AB
![]() SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Health Technology |
Knobe Strat&Med AB | |
Fastighets AB Swenson & Co. |
- Stock Market
- Insiders
- Jens Knobe
- Experience